Psychedelic-assisted therapy involves certain approaches to ‘talk-therapy’ alongside the ingestion of a psychedelic compound such as psilocybin or MDMA. In this presentation, Prof David Castle, Chair of Psychiatry at St Vincent’s Health and The University of Melbourne, describes two broad types of Medicine-Assisted Psychotherapies: Medical Psilocybin for Depression, and Medicinal MDMA for Post Traumatic Stress Disorder (PTSD), based on strong clinical evidence.
- Understanding of the three distinct therapy phases - preparation, the psychedelic experience, and integration
- The importance of the non-psychedelic elements of this approach for both effectiveness and safety.
- The benefits and potential outcomes, such as substantial increases in self-awareness, self-compassion, insight, connectedness and meaning
- How Medicinal Psilocybin Assisted-Psychotherapy works in patients with depression.
- How Medicinal MDMA Psychotherapy for PTSD decreases fear and defensiveness.
- Outline of several international trials of these therapies Including Australia’s first clinical trial.
Video Lecture (22 mins of CPD)
Test your learning!